Home > H3D News > News

News

Current news articles are found here.

UCT KEY IN NEW DRUGS SEARCH
Friday, June 29, 2018 - 14:00
The University of Cape Town’s Drug Discovery and Development Centre (H3D) will be pivotal in a new international drug discovery programme aimed at financing not only the identification of new drug candidates to combat diseases such as malaria and tuberculosis, but also the development of African scientists.
OPEN CALL FOR LETTER OF INTENT (LOI) ON DRUG DISCOVERY
Monday, April 23, 2018 - 14:00
1. Background

Drug discovery excellence is a critical prerequisite for success in drug development and remains a highly neglected area for the African continent. The lack of market incentives has biased drug discovery efforts globally away from diseases most prevalent in the developing world. Collaborative efforts of multidisciplinary teams – in drug discovery and other fields – shows that success and efficiency increases significantly when individual contributors combine their complementary capabilities. The whole is greater than the sum of its parts. State-of-the-art approaches to implementing drug discovery projects, especially when the goal is to also build drug discovery capability on the African continent, need to be supported.

PIONEER OF WORLD CLASS DRUG DISCOVERY CENTRE IN AFRICA IS NAMED ONE OF FORTUNE’S 50 WORLD’S GREATEST LEADERS FOR 2018
Monday, April 23, 2018 - 14:00

The founder and director of Africa’s first integrated drug discovery centre, Professor Kelly Chibale, has been named as one of Fortune magazine’s World’s Greatest Leaders for 2018.

Chibale, whose H3D centre at the University of Cape Town pioneers world-class drug discovery in Africa, has also become known for his pivotal work on malaria.

THE WORLD'S 50 GREATEST LEADERS
Thursday, April 19, 2018 - 18:00

45. Kelly Chibale

Scientist, South Africa

In much of Africa, the infrastructure to support scientific research is sorely lacking. But Chibale is working to change that. The Zambian chemist has built H3D, Africa’s first integrated drug discovery center, at the University of Cape Town. His team now includes more than 90 researchers; they work out of state-of-the-art facilities thanks to partnerships with the Gates Foundation, Novartis, and South Africa’s government. H3D already has a potential drug for ­malaria in human trials.

Project team
MERCK, UNIVERSITY OF CAPE TOWN AND MEDICINES FOR MALARIA VENTURE JOIN FORCES TO FEED THE ANTIMALARIAL PIPELINE
Thursday, April 19, 2018 - 15:00
Merck, the University of Cape Town and Medicines for Malaria Venture create an antimalarial drug discovery platform, strengthening their partnership in the fight against malaria The partners will collaborate to build research capacity in Africa
EXPRESSO INTERVIEW
Wednesday, February 21, 2018 - 18:00

Expresso Show

We chat with Professor Kelly Chibale from the South African Medical Research Council to get an update on Malaria and which hotspots to watch out for over the festive season.

 

ANOTHER WIN FOR H3D AS KELLY CHIBALE ACHIEVES A-RATING
Wednesday, December 20, 2017 - 18:00

Having grown up in the villages and townships of Zambia, Professor Kelly Chibale became well acquainted with the ravages of malaria at a young age. Now, inspired by a deep spirituality and a love of chemistry, his invaluable contribution to the ongoing battle against this disease – among others – has been awarded an A rating by the National Research Foundation.

 

19th RSC/ SCI MEDICINAL CHEMISTRY SYMPOSIUM
Friday, October 6, 2017 - 18:00

MedChemNet and Infectious Diseases Hub were absolutely delighted to attend the first two days of the recent 19th RSC / SCI Medicinal Chemistry Symposium – Europe’s premier biennial Medicinal Chemistry event – focusing on first disclosures of significant new therapeutic agents across all disease areas and new strategies in medicinal chemistry.

FIGHTING MALARIA IN THE LAB
Friday, October 6, 2017 - 18:00

Kelly Chibale, Professor of Organic Chemistry at Cape Town University in South Africa, talks about his drug discovery work and coming up with compounds that might have an impact on malaria control and elimination

YouTube Link

FIVE QUESTIONS WITH PROF. KELLY CHIBALE
Friday, October 6, 2017 - 18:00

This week, we were fortunate to catch up with Professor Kelly Chibale, Principal Investigator at the University of Cape Town, founder of Africa’s first drug discovery and development centre, H3D, and one of the speakers at our #ScienceAfrica UnConference this year. Professor Chibale spoke eloquently about his efforts to create novel medicines to combat the major diseases in Africa as well as his concerted advocacy for greater investment in hard scientific infrastructure.

Mosquito biting a human finger
COMMUNITY OF PRACTICE IN MALARIA ELIMINATION HOSTED AT UP
Friday, August 4, 2017 - 18:00

The University of Pretoria (UP) will host its first Community of Practice (CoP) focusing specifically on Malaria Elimination in the UP Institute for Sustainable Malaria Control (UP ISMC). This NRF initiative endeavours to provide ‘vehicles to enable the implementation of integrated trans-disciplinary and multi-disciplinary solutions to address societal challenges and to ultimately bring change to the lives of South Africans.

Dr Mathew Njoroge (H3D), in laboratory
NJOROGE TAKES NOTES FROM LAUREATES IN LINDAU
Friday, August 4, 2017 - 18:00

Postdoctoral research fellow Dr Mathew Njoroge at UCT’s Drug Discovery and Development Centre (H3D) recently returned from the 67th Lindau Nobel Laureate Meeting in Germany. The annual scientific conferences have been held in Lindau since 1951, bringing together Nobel laureates and young scientists to foster scientific exchanges between different generations and cultures.

Pages